1. Home
  2. RNXT vs AAME Comparison

RNXT vs AAME Comparison

Compare RNXT & AAME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • AAME
  • Stock Information
  • Founded
  • RNXT 2012
  • AAME 1968
  • Country
  • RNXT United States
  • AAME United States
  • Employees
  • RNXT N/A
  • AAME N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • AAME Life Insurance
  • Sector
  • RNXT Health Care
  • AAME Finance
  • Exchange
  • RNXT Nasdaq
  • AAME Nasdaq
  • Market Cap
  • RNXT 31.6M
  • AAME 30.3M
  • IPO Year
  • RNXT 2021
  • AAME N/A
  • Fundamental
  • Price
  • RNXT $1.16
  • AAME $1.59
  • Analyst Decision
  • RNXT Strong Buy
  • AAME
  • Analyst Count
  • RNXT 1
  • AAME 0
  • Target Price
  • RNXT $9.00
  • AAME N/A
  • AVG Volume (30 Days)
  • RNXT 203.6K
  • AAME 6.3K
  • Earning Date
  • RNXT 03-31-2025
  • AAME 03-31-2025
  • Dividend Yield
  • RNXT N/A
  • AAME 2.55%
  • EPS Growth
  • RNXT N/A
  • AAME N/A
  • EPS
  • RNXT N/A
  • AAME N/A
  • Revenue
  • RNXT N/A
  • AAME $185,929,000.00
  • Revenue This Year
  • RNXT N/A
  • AAME N/A
  • Revenue Next Year
  • RNXT N/A
  • AAME N/A
  • P/E Ratio
  • RNXT N/A
  • AAME N/A
  • Revenue Growth
  • RNXT N/A
  • AAME 0.35
  • 52 Week Low
  • RNXT $0.77
  • AAME $1.26
  • 52 Week High
  • RNXT $1.86
  • AAME $3.00
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 38.10
  • AAME 48.35
  • Support Level
  • RNXT $1.32
  • AAME $1.58
  • Resistance Level
  • RNXT $1.40
  • AAME $1.72
  • Average True Range (ATR)
  • RNXT 0.09
  • AAME 0.11
  • MACD
  • RNXT -0.03
  • AAME -0.01
  • Stochastic Oscillator
  • RNXT 17.07
  • AAME 45.45

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About AAME Atlantic American Corporation

Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts. It also provides tailored business automobile insurance coverage, on a multi-year contract basis, to state governments and local municipalities, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance. It earns revenue from the collection of premiums and investment income.

Share on Social Networks: